Volume 10, Issue 4

December 2019

Predictive, Preventive and Personalised Medical Approach, Phenotyping and Multi-omic Tools Applied to Chronic Inflammation, Healing Impairment, Cancer, Cardiovascular and Neurodegenerative Disorders

Issue Editors:

Babak Baban,
Rostyslav Bubnov,
Vincenzo Costigliola,
Yoshihiro Kokubo,
Mahmood Mozaffari,
Byong Chul Yoo,
Xianquan Zhan

10 articles in this issue

Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice
Rostyslav Bubnov
Lidiia Babenko
Mykola Spivak
Research 29 October 2019 Pages: 317 - 335
Probiotic Lactobacillus and Bifidobacterium strains possess safety characteristics, antiviral activities and host adherence factors revealed by genome mining
Ahmed Ghamry Abdelhamid
Samar S. El-Masry
Noha K. El-Dougdoug
Research 05 September 2019 Pages: 337 - 350
Immunohistological staining of unknown chemokine RANTES/CCL5 expression in jawbone marrow defects—osteoimmunology and disruption of bone remodeling in clinical case studies targeting on predictive preventive personalized medicine
Johann Lechner
Tilman Schulz
Volker von Baehr
Research Open access 06 August 2019 Pages: 351 - 364
Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles
Shehua Qian
Olga Golubnitschaja
Xianquan Zhan
Review Open access 20 November 2019 Pages: 365 - 381
Development of a membrane lipid metabolism–based signature to predict overall survival for personalized medicine in ccRCC patients
Maode Bao
Run Shi
Xuanwen Bao
Research 07 November 2019 Pages: 383 - 393
TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas
Ya Wang
Tingting Cheng
Xianquan Zhan
Research Open access 29 August 2019 Pages: 395 - 414
Abdominal aortic aneurysm in prostate cancer patients: the “road map” from incidental detection to advanced predictive, preventive, and personalized approach utilizing common follow-up for both pathologies
Jiri Ferda
Jan Baxa
Jiri Molacek
Research 26 November 2019 Pages: 415 - 423
Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials
Sinje Gehr
Thomas Kaiser
Friedemann Paul
Review Open access 22 November 2019 Pages: 425 - 436
Flammer syndrome in multiple sclerosis: diagnostics, prediction, and personalization of treatments
Cihat Uzunköprü
Yeşim Beckmann
Research 10 August 2019 Pages: 437 - 444
Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care
Matthew Barrett
Josiane Boyne
Bettina Zippel-Schultz
Review Open access 22 November 2019 Pages: 445 - 464

Volume 10, Issue 4

Can tailored nanoceria act as a prebiotic? Report on improved lipid profile and gut microbiota in obese mice

Probiotic Lactobacillus and Bifidobacterium strains possess safety characteristics, antiviral activities and host adherence factors revealed by genome mining

Immunohistological staining of unknown chemokine RANTES/CCL5 expression in jawbone marrow defects—osteoimmunology and disruption of bone remodeling in clinical case studies targeting on predictive preventive personalized medicine

Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles

Development of a membrane lipid metabolism–based signature to predict overall survival for personalized medicine in ccRCC patients

TMT-based quantitative proteomics revealed follicle-stimulating hormone (FSH)-related molecular characterizations for potentially prognostic assessment and personalized treatment of FSH-positive non-functional pituitary adenomas

Abdominal aortic aneurysm in prostate cancer patients: the “road map” from incidental detection to advanced predictive, preventive, and personalized approach utilizing common follow-up for both pathologies

Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials

Flammer syndrome in multiple sclerosis: diagnostics, prediction, and personalization of treatments

Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care

Navigation

Volume 10, Issue 4

Search

Navigation